CCDC86 and glioma: Knockdown and overexpression efficiencies were validated (Fig. S4A, B), and subsequent cell functional experiments demonstrated that CCDC86 overexpression promoted glioma cell proliferation and migration, while ATF3 down-regulation inhibited these phenotypes, even reversing the pro-cancer effects of CCDC86 overexpression (Fig. 4A, B).